Luis Garza, M.D., Ph.D., on What Hidradenitis Suppurativa Is Not
Luis Garza, M.D., Ph.D., defines hidradenitis suppurativa by its misconceptions in a new interview — a corrective aimed at the diagnostic delays HS patients face.
Topic
Topic
Luis Garza, M.D., Ph.D., defines hidradenitis suppurativa by its misconceptions in a new interview — a corrective aimed at the diagnostic delays HS patients face.
Dermatology Times' Case 2 examines escalation strategy after biologic failure in hidradenitis suppurativa, where approved options…
Frontiers has published a comprehensive review on the link between atopic dermatitis and rosacea, mapping shared comorbidities an…
A new Frontiers review argues psoriasis and atopic dermatitis reprogram immune metabolism in opposite directions, with implicatio…
A Cureus narrative review compares long-term cardiovascular, thromboembolic and malignancy safety of JAK inhibitors in dermatolog…
Expert guidance from HCPlive focuses on optimizing HS biologics, combination therapy and surgical timing in hidradenitis suppurat…
HCPLive's latest report on hidradenitis suppurativa centers expectation-setting, comorbidity screening, and structured wound care…
Jennifer Hsiao, MD, shares practical tips on HS treatment selection and comorbidity screening in a new Dermatology Times conversa…
Sanofi has committed up to $8 billion to expand its antibody-development partnership with Regeneron. The renewed agreement center…
October 5 marks the inaugural World Chronic Hand Eczema Day, a new global observance raising awareness of an often-overlooked ski…